Elizabeth A Gilliams1, Jibreel Jumare2, Cassidy W Claassen3, Phillip C Thesing4, Osward M Nyirenda4, Fraction K Dzinjalamala5, Terrie Taylor6, Christopher V Plowe3, LaRee A Tracy2, Miriam K Laufer3. 1. Department of Epidemiology and Public Health, University of Maryland School of Medicine Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland. 2. Department of Epidemiology and Public Health, University of Maryland School of Medicine. 3. Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland. 4. Blantyre Malaria Project, University of Malawi College of Medicine. 5. Department of Pharmacy, University of Malawi College of Medicine, Blantyre, Malawi. 6. Blantyre Malaria Project, University of Malawi College of Medicine Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, E. Lansing, Michigan.
Abstract
BACKGROUND:Chloroquine-azithromycin is being evaluated as combination therapy for malaria. It may provide added benefit in treating or preventing bacterial infections that occur in children with malaria. OBJECTIVE: We aim to evaluate the effect of treating clinical malaria with chloroquine-azithromycin on the incidence of respiratory-tract and gastrointestinal-tract infections compared to treatment with chloroquine monotherapy. METHODS: We compared the incidence density and time to first events of respiratory-tract and gastrointestinal-tract infections among children assigned to receive chloroquine-azithromycin or chloroquine for all symptomatic malaria episodes over the course of 1 year in a randomized longitudinal trial in Blantyre, Malawi. RESULTS: The incidence density ratios of total respiratory-tract infections and gastrointestinal-tract infections comparing chloroquine-azithromycin to chloroquine monotherapy were 0.67 (95% confidence interval [CI], .48, .94) and 0.74 (95% CI, .55, .99), respectively. The time to first lower-respiratory-tract and gastrointestinal-tract infections were significantly longer in the chloroquine-azithromycin arm compared to the chloroquine arm (P = .04 and P = .02, respectively). CONCLUSIONS: Children treated routinely with chloroquine-azithromycin had fewer respiratory and gastrointestinal-tract infections than those treated with chloroquine alone. This antimalarial combination has the potential to reduce the burden of bacterial infections among children in malaria-endemic countries.
RCT Entities:
BACKGROUND:Chloroquine-azithromycin is being evaluated as combination therapy for malaria. It may provide added benefit in treating or preventing bacterial infections that occur in children with malaria. OBJECTIVE: We aim to evaluate the effect of treating clinical malaria with chloroquine-azithromycin on the incidence of respiratory-tract and gastrointestinal-tract infections compared to treatment with chloroquine monotherapy. METHODS: We compared the incidence density and time to first events of respiratory-tract and gastrointestinal-tract infections among children assigned to receive chloroquine-azithromycin or chloroquine for all symptomatic malaria episodes over the course of 1 year in a randomized longitudinal trial in Blantyre, Malawi. RESULTS: The incidence density ratios of total respiratory-tract infections and gastrointestinal-tract infections comparing chloroquine-azithromycin to chloroquine monotherapy were 0.67 (95% confidence interval [CI], .48, .94) and 0.74 (95% CI, .55, .99), respectively. The time to first lower-respiratory-tract and gastrointestinal-tract infections were significantly longer in the chloroquine-azithromycin arm compared to the chloroquine arm (P = .04 and P = .02, respectively). CONCLUSIONS:Children treated routinely with chloroquine-azithromycin had fewer respiratory and gastrointestinal-tract infections than those treated with chloroquine alone. This antimalarial combination has the potential to reduce the burden of bacterial infections among children in malaria-endemic countries.
Authors: A J Matute; C A M Schurink; R M C Krijnen; A Florijn; M Rozenberg-Arska; I M Hoepelman Journal: Eur J Clin Microbiol Infect Dis Date: 2002-06-11 Impact factor: 3.267
Authors: A M Fry; H C Jha; T M Lietman; J S P Chaudhary; R C Bhatta; J Elliott; T Hyde; A Schuchat; B Gaynor; S F Dowell Journal: Clin Infect Dis Date: 2002-07-23 Impact factor: 9.079
Authors: Harald Noedl; Youry Se; Kurt Schaecher; Bryan L Smith; Duong Socheat; Mark M Fukuda Journal: N Engl J Med Date: 2008-12-08 Impact factor: 91.245
Authors: Miriam K Laufer; Phillip C Thesing; Nicole D Eddington; Rhoda Masonga; Fraction K Dzinjalamala; Shannon L Takala; Terrie E Taylor; Christopher V Plowe Journal: N Engl J Med Date: 2006-11-09 Impact factor: 91.245
Authors: Igor Rudan; Cynthia Boschi-Pinto; Zrinka Biloglav; Kim Mulholland; Harry Campbell Journal: Bull World Health Organ Date: 2008-05 Impact factor: 9.408
Authors: James G Kublin; Joseph F Cortese; Eric Mbindo Njunju; Rabia A G Mukadam; Jack J Wirima; Peter N Kazembe; Abdoulaye A Djimdé; Bourema Kouriba; Terrie E Taylor; Christopher V Plowe Journal: J Infect Dis Date: 2003-05-21 Impact factor: 5.226
Authors: Craig W See; Kieran S O'Brien; Jeremy D Keenan; Nicole E Stoller; Bruce D Gaynor; Travis C Porco; Thomas M Lietman Journal: Am J Trop Med Hyg Date: 2015-09-21 Impact factor: 2.345
Authors: Brioni R Moore; John M Benjamin; Roselyn Tobe; Maria Ome-Kaius; Gumul Yadi; Bernadine Kasian; Charles Kong; Leanne J Robinson; Moses Laman; Ivo Mueller; Stephen Rogerson; Timothy M E Davis Journal: Antimicrob Agents Chemother Date: 2019-09-23 Impact factor: 5.191
Authors: Brioni R Moore; John M Benjamin; Siu On Auyeung; Sam Salman; Gumul Yadi; Suzanne Griffin; Madhu Page-Sharp; Kevin T Batty; Peter M Siba; Ivo Mueller; Stephen J Rogerson; Timothy Me Davis Journal: Br J Clin Pharmacol Date: 2016-03-27 Impact factor: 4.335
Authors: Gabrielle B McCallum; Peter S Morris; Keith Grimwood; Carolyn Maclennan; Andrew V White; Mark D Chatfield; Theo P Sloots; Ian M Mackay; Heidi Smith-Vaughan; Clare C McKay; Lesley A Versteegh; Nerida Jacobsen; Charmaine Mobberley; Catherine A Byrnes; Anne B Chang Journal: Front Pediatr Date: 2015-04-21 Impact factor: 3.418
Authors: James A Berkley; Moses Ngari; Johnstone Thitiri; Laura Mwalekwa; Molline Timbwa; Fauzat Hamid; Rehema Ali; Jimmy Shangala; Neema Mturi; Kelsey D J Jones; Hassan Alphan; Beatrice Mutai; Victor Bandika; Twahir Hemed; Ken Awuondo; Susan Morpeth; Samuel Kariuki; Gregory Fegan Journal: Lancet Glob Health Date: 2016-06-02 Impact factor: 38.927